Capricor Therapeutics Inc (CAPR)
6.20
+0.56
(+9.93%)
USD |
NASDAQ |
May 17, 16:00
6.22
+0.02
(+0.32%)
After-Hours: 20:00
Capricor Therapeutics Cash from Operations (TTM): -31.08M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -31.08M |
December 31, 2023 | -25.60M |
September 30, 2023 | -20.90M |
June 30, 2023 | -17.80M |
March 31, 2023 | -14.92M |
December 31, 2022 | 4.917M |
September 30, 2022 | 6.191M |
June 30, 2022 | 8.539M |
March 31, 2022 | 10.57M |
December 31, 2021 | -16.81M |
September 30, 2021 | -15.02M |
June 30, 2021 | -14.66M |
March 31, 2021 | -12.17M |
December 31, 2020 | -10.05M |
September 30, 2020 | -7.997M |
June 30, 2020 | -6.671M |
March 31, 2020 | -6.432M |
December 31, 2019 | -6.822M |
September 30, 2019 | -8.808M |
June 30, 2019 | -10.14M |
March 31, 2019 | -12.05M |
December 31, 2018 | -13.86M |
September 30, 2018 | -12.76M |
June 30, 2018 | -12.97M |
March 31, 2018 | -12.97M |
Date | Value |
---|---|
December 31, 2017 | -14.23M |
September 30, 2017 | -15.04M |
June 30, 2017 | -13.76M |
March 31, 2017 | -14.95M |
December 31, 2016 | -14.45M |
September 30, 2016 | -14.62M |
June 30, 2016 | -15.95M |
March 31, 2016 | -12.95M |
December 31, 2015 | -10.82M |
September 30, 2015 | -9.321M |
June 30, 2015 | -8.298M |
March 31, 2015 | -12.44M |
December 31, 2014 | 0.9586M |
September 30, 2014 | 3.285M |
June 30, 2014 | 0.9948M |
March 31, 2014 | 6.375M |
December 31, 2013 | -6.144M |
September 30, 2013 | -6.436M |
June 30, 2013 | -2.418M |
March 31, 2013 | -2.635M |
December 31, 2012 | -2.063M |
September 30, 2012 | -3.520M |
June 30, 2012 | -3.677M |
March 31, 2012 | -3.992M |
December 31, 2011 | -4.649M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-31.08M
Minimum
Mar 2024
10.57M
Maximum
Mar 2022
-9.783M
Average
-10.10M
Median
Cash from Operations (TTM) Benchmarks
Sarepta Therapeutics Inc | -533.67M |
PTC Therapeutics Inc | -58.17M |
Solid Biosciences Inc | -91.38M |
Inovio Pharmaceuticals Inc | -116.46M |
Stereotaxis Inc | -8.683M |